We are committed to making a meaningful impact on patients' lives.

Our mission is to develop transformative medicines for orphan diseases of the kidney.

  • Life-threatening Genetic Disease
  • 4th Leading Cause of Kidney Failure
  • Limited Treatment Options
  • Learn More
Please visit our website again for updates on ELiSA, our Phase 2 clinical study in patients with Autosomal Dominant Polycystic Kidney Disease.